CASP1 and metabolic dysfunction-associated steatotic liver disease: It has been reported that arsenic trioxide (As2O3) resulted in the nonalcoholic fatty liver disease/nonalcoholic steatohepatitis by inducing the classic pyroptosis pathway in HepG2 cells, accompanied by up-regulating the protein expressions of Caspase-1 and IL-1β [14].